Zurich Cantonal Bank
NRIX icon

Zurich Cantonal Bank’s Nurix Therapeutics NRIX Stock Holding History

Zurich Cantonal Bank’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.37M Buy
97,567
+56,639
+138% +$965K ﹤0.01% 1036
2026
Q1 		$634K Buy
40,928
+9,737
+31% +$161K ﹤0.01% 1708
2025
Q4 		$592K Buy
31,191
+12,362
+66% +$178K ﹤0.01% 1687
2025
Q3 		$174K Hold
18,829
– – ﹤0.01% 2251
2025
Q2 		$214K Hold
18,829
– – ﹤0.01% 2102
2025
Q1 		$224K Buy
18,829
+2,260
+14% +$37.8K ﹤0.01% 2042
2024
Q4 		$312K Buy
16,569
+1,401
+9% +$32.1K ﹤0.01% 1922
2024
Q3 		$341K Sell
15,168
-39
-0.3% -$883 ﹤0.01% 1801
2024
Q2 		$317K Buy
15,207
+13,444
+763% +$209K ﹤0.01% 1793
2024
Q1 		$25.9K Buy
+1,763
New +$19K ﹤0.01% 2614
2023
Q4 		– Sell
-5,482
Closed -$43.1K – 2769
2023
Q3 		$43.1K Sell
5,482
-1
-0% -$9 ﹤0.01% 2626
2023
Q2 		$54.8K Hold
5,483
– – ﹤0.01% 2593
2023
Q1 		$48.7K Sell
5,483
-829
-13% -$8.64K ﹤0.01% 2601
2022
Q4 		$69.3K Buy
6,312
+1,194
+23% +$14.4K ﹤0.01% 2486
2022
Q3 		$67K Hold
5,118
– – ﹤0.01% 2474
2022
Q2 		$65K Hold
5,118
– – ﹤0.01% 2480
2022
Q1 		$72K Buy
5,118
+1,071
+26% +$19K ﹤0.01% 2418
2021
Q4 		$117K Buy
+4,047
New +$123K ﹤0.01% 2423

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Zurich Cantonal Bank's NRIX Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Nurix Therapeutics (NRIX) stake by 138% in Q2 2026, buying an estimated $965K and bringing the position to 97,567 shares worth $2.37M. The position accounts for ﹤0.01% of the portfolio, ranked #1036.

Zurich Cantonal Bank first reported a position in NRIX in Q4 2021 and has held it in 18 quarters since. 211 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • Zurich Cantonal Bank held 97,567 shares of Nurix Therapeutics worth $2.37M as of Q2 2026.
  • Zurich Cantonal Bank bought 56,639 Nurix Therapeutics shares in Q2 2026, an estimated $965K.
  • Nurix Therapeutics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1036 holding.
  • Zurich Cantonal Bank first reported a position in Nurix Therapeutics in Q4 2021 and has held it in 18 quarters since.
  • 211 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.